Detalhe da pesquisa
1.
Direct oral anticoagulants: patient reported adherence and minor bleedings.
J Thromb Thrombolysis
; 56(1): 55-64, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37119356
2.
Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era.
Br J Haematol
; 169(5): 683-8, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25817799
3.
IFNγ directly counteracts imatinib-induced apoptosis of primary human CD34+ CML stem/progenitor cells potentially through the upregulation of multiple key survival factors.
Oncoimmunology
; 11(1): 2109861, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35979386
4.
Quality of life, physical function and MRI T2* in elderly low-risk MDS patients treated to a haemoglobin level of ≥120 g/L with darbepoetin alfa ± filgrastim or erythrocyte transfusions.
Eur J Haematol
; 87(3): 244-52, 2011 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-21623919
5.
Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells.
Cell Death Dis
; 12(10): 875, 2021 09 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-34564697
6.
Maintenance treatment with azacytidine for patients with high-risk myelodysplastic syndromes (MDS) or acute myeloid leukaemia following MDS in complete remission after induction chemotherapy.
Br J Haematol
; 150(3): 293-302, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20497178
7.
Negative effect of DNA hypermethylation on the outcome of intensive chemotherapy in older patients with high-risk myelodysplastic syndromes and acute myeloid leukemia following myelodysplastic syndrome.
Clin Cancer Res
; 13(23): 7107-12, 2007 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18056190
8.
Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis.
Oncol Rep
; 40(2): 902-908, 2018 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-29845257
9.
Modulation of leukotriene signaling inhibiting cell growth in chronic myeloid leukemia.
Leuk Lymphoma
; 58(8): 1903-1913, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27931141
10.
Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia.
Leuk Lymphoma
; 55(12): 2769-77, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24524339
11.
Bleeding complications during warfarin treatment in primary healthcare centres compared with anticoagulation clinics.
Scand J Prim Health Care
; 25(2): 123-8, 2007 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-17497491
12.
Serum erythropoietin (EPO) levels correlate with survival and independently predict response to EPO treatment in patients with myelodysplastic syndromes.
Eur J Haematol
; 68(3): 180-5, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-12068800
13.
Oral cladribine for B-cell chronic lymphocytic leukaemia: report of a phase II trial with a 3-d, 3-weekly schedule in untreated and pretreated patients, and a long-term follow-up of 126 previously untreated patients.
Br J Haematol
; 116(3): 538-48, 2002 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-11849209